/
/
/

Lincoln Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)627.00
Volume (₹)21,674.00
High (₹)631.00
Upper Circuit747.15
Low (₹)618.05
Lower Circuit498.15
Prev Close622.65
52W High (₹)770.00
Price624.80
52W Low (₹)440.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)1247.65 Cr
Div. Yield (%)0.29
PE Ratio12.94
Debt to Equity0.00
Price to Book1.64
Book Value335.34
EPS (TTM)48.15
Face Value10.00
ROE (%)13.02

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LINCOLNNSE
LTP
1W Low
1W High
Market cap (₹)
1899.1-20.9 (-1.09%)
1896.80
1984.80
4,56,833Cr
9134.5-104.5 (-1.13%)
9087
9467
2,45,426Cr
4841-209 (-4.14%)
4823
5066
1,87,320Cr
1129.9-61.1 (-5.13%)
1125.10
1187
1,13,217Cr
1380.4-43.1 (-3.03%)
1376
1426.10
1,12,212Cr
1843.1-95.4 (-4.92%)
1811.70
1949
1,01,155Cr
2110-61.5 (-2.83%)
2107.20
2192
97,626Cr
2330.5-52.4 (-2.20%)
2327.30
2419.20
96,859Cr
1158-20 (-1.70%)
1154.40
1179.90
96,406Cr
1653.3+8 (0.49%)
1622.60
1717
93,614Cr
624.8+9.85 (1.60%)
603.35
631
1,248Cr

Key Highlights of Lincoln Pharmaceuticals Ltd Balance Sheet

Lincoln Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹20.03Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹20.03Cr, and the reserves and surplus of the company is ₹651.64Cr.

The company has its non-current liabilities with total liabilities of ₹821.74Cr as of 2025-03-31.

The current liabilities are ₹130.95Cr as of 2025-03-31. At the same time, current assets are ₹524.62Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹5.26Lakh and tangible assets of ₹181.97Cr, provided in the Lincoln Pharmaceuticals Ltd financial statements.